We just received data on a new analyst forecast for $VRNA. Piper Sandler gave a rating of 'Overweight' for $VRNA.
$VRNA Analyst Ratings
Wall Street analysts have issued reports on $VRNA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 06/23/2025
- Cowen & Co. issued a "Buy" rating on 04/28/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/21/2025
- Wells Fargo issued a "Overweight" rating on 01/08/2025
- BTIG issued a "Buy" rating on 01/08/2025
To track analyst ratings and price targets for $VRNA, check out Quiver Quantitative's $VRNA forecast page.
$VRNA Price Targets
Multiple analysts have issued price targets for $VRNA recently. We have seen 4 analysts offer price targets for $VRNA in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- An analyst from Piper Sandler set a target price of $160.0 on 06/23/2025
- An analyst from Cantor Fitzgerald set a target price of $80.0 on 04/21/2025
- Boobalan Pachaiyappan from Roth Capital set a target price of $68.0 on 01/10/2025
- Tiago Fauth from Wells Fargo set a target price of $74.0 on 01/08/2025
$VRNA Insider Trading Activity
$VRNA insiders have traded $VRNA stock on the open market 28 times in the past 6 months. Of those trades, 0 have been purchases and 28 have been sales.
Here’s a breakdown of recent trading of $VRNA stock by insiders over the last 6 months:
- DAVID ZACCARDELLI (President and CEO) has made 0 purchases and 8 sales selling 1,477,368 shares for an estimated $14,417,810.
- MARK W HAHN (Chief Financial Officer) has made 0 purchases and 8 sales selling 1,477,368 shares for an estimated $14,417,216.
- KATHLEEN A. RICKARD (Chief Medical Officer) has made 0 purchases and 5 sales selling 277,832 shares for an estimated $2,425,402.
- ANDREW FISHER (General Counsel) has made 0 purchases and 3 sales selling 186,072 shares for an estimated $1,841,726.
- VIKAS SINHA has made 0 purchases and 3 sales selling 180,000 shares for an estimated $1,681,344.
- CHRISTINA ACKERMANN sold 40,000 shares for an estimated $337,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNA Hedge Fund Activity
We have seen 153 institutional investors add shares of $VRNA stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 3,849,724 shares (+230.9%) to their portfolio in Q1 2025, for an estimated $244,418,976
- DARWIN GLOBAL MANAGEMENT, LTD. added 3,112,755 shares (+384.1%) to their portfolio in Q1 2025, for an estimated $197,628,814
- NEA MANAGEMENT COMPANY, LLC removed 2,896,188 shares (-51.9%) from their portfolio in Q1 2025, for an estimated $183,878,976
- RA CAPITAL MANAGEMENT, L.P. removed 1,766,830 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $112,176,036
- HOLOCENE ADVISORS, LP added 1,366,680 shares (+inf%) to their portfolio in Q1 2025, for an estimated $86,770,513
- MAVERICK CAPITAL LTD removed 1,345,018 shares (-43.0%) from their portfolio in Q1 2025, for an estimated $85,395,192
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,292,575 shares (+381.9%) to their portfolio in Q1 2025, for an estimated $82,065,586
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
